Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells

被引:21
作者
Sun, Yuan [1 ,4 ]
Li, Ying-xia [2 ]
Wu, Hai-jun [2 ]
Wu, Si-hung [1 ]
Wang, Y. Alan [3 ]
Luo, Dian-zhong [4 ]
Liao, D. Joshua [1 ]
机构
[1] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA
[2] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[3] Harvard Univ, Dana Farber Canc Inst, Discovery Ctr Appl Canc Sci, Boston, MA 02115 USA
[4] Guanxi Med Univ, Dept Pathol, Nanning 530021, Guangxi, Peoples R China
关键词
NPCD; CDK4; Inhibitor; breast cancer cell lines; DEPENDENT KINASE INHIBITORS; TRIGGER PROTEASOMAL DEGRADATION; CYCLIN D1 EXPRESSION; IN-VIVO; PHARMACOLOGICAL INHIBITION; ANTITUMOR-ACTIVITY; MOLECULAR EVIDENCE; MYELOMA CELLS; G(1) CYCLINS; C-MYC;
D O I
10.7150/jca.2.36
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Cyclin D1 (D1) binds to cyclin-dependent kinases (CDK) 4 or 6 to form a holoenzyme that phosphorylates the Rb protein to promote cell cycle progression from G1 to S phase. Therefore, targeting CDK4/6 may be a good strategy for chemotherapy of cancer. We performed a proof-of-principle study to determine the effect of Naphtho [2, 1-alpha] pyrrolo [3, 4-c] carbazole-5, 7 (6H, 12H)-dione (NPCD), a novel CDK4 inhibitor, on breast cancer cell lines. Methods: NPCD was synthesized and purified to over 99% purity verified by HPLC. MCF7, MB231, MCF15, T47D and GI101Ap human breast cancer cells were analyzed for the efficacy of NPCD with MTT and clonogenic assays, with FACS and staining for ethidium bromide and acridine orange for cell death and cell cycle profile. Western blot, reverse transcription and PCR were used for studies of gene expression, and co-immunoprecipitation for protein-complex formation. Results: MTT assay showed that NPCD caused growth arrest and apoptosis of MCF7, MDA-MB231, T47D, MCF15 and GI101Ap cells with an IC50 ranging between 3 to 8 mu M given as a single dose. The growth arrest persisted for many days after cessation of the treatment, as shown in a clonogenic assay. NPCD could induce or reduce the D1 and CDK4 protein levels, depending on the cell line, but this effect was not correlated with its efficacy. Phosphorylation of D1 at Thr286 was decreased but it unexpectedly did not correlate with the change in D1 level in the cell lines studied. Phosphorylation of the Rb protein was decreased as expected whereas the p27kip1 protein level was decreased unexpectedly. Protein levels of p21 cip1, CDK2 and cyclin E were also decreased in some, but not all, of the cell lines, whereas the mRNA levels of D1, CDK4, cyclin E, CDK2, p27kip1 and p21cip1 were increased in different cell lines. Conclusions: NPCD can cause long-lasting growth arrest and cell death of breast cancer cell lines at an IC50 of 3-8 mu M. Decreased phosphorylation of Rb by D1-CDK4/6 and decreased p27kip1 protein level may be part of the underlying mechanism.
引用
收藏
页码:36 / 51
页数:16
相关论文
共 83 条
[1]  
Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744
[2]   Molecular targets and anticancer potential of indole-3-carbinol and its derivatives [J].
Aggarwal, BB ;
Ichikawa, H .
CELL CYCLE, 2005, 4 (09) :1201-1215
[3]   The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention [J].
Alao, John P. .
MOLECULAR CANCER, 2007, 6 (1)
[4]   Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro [J].
Alimova, Irina N. ;
Liu, Bolin ;
Fan, Zeying ;
Edgerton, Susan M. ;
Dillon, Thomas ;
Lind, Stuart E. ;
Thor, Ann D. .
CELL CYCLE, 2009, 8 (06) :909-915
[5]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[6]   Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model [J].
Appleyard, Maria Virginia C. L. ;
O'Neill, Mary A. ;
Murray, Karen E. ;
Paulin, Fiona E. M. ;
Bray, Susan E. ;
Kernohan, Neil M. ;
Levison, David A. ;
Lane, David P. ;
Thompson, Alastair M. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (02) :465-472
[7]   Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1 [J].
Aubry, Carine ;
Wilson, A. James ;
Emmerson, Daniel ;
Murphy, Emma ;
Chan, Yu Yam ;
Dickens, Michael P. ;
Garcia, Marcos D. ;
Jenkins, Paul R. ;
Mahale, Sachin ;
Chaudhuri, Bhabatosh .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (16) :6073-6084
[8]   Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer [J].
Banerjee, S ;
Zhang, YX ;
Ali, S ;
Bhuiyan, M ;
Wang, ZW ;
Chiao, PJ ;
Philip, PA ;
Abbruzzese, J ;
Sarkar, FH .
CANCER RESEARCH, 2005, 65 (19) :9064-9072
[9]   RETRACTED: In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer (Retracted article.See vol.139, pg.2145,2016) [J].
Banerjee, Sanjeev ;
Zhang, Yuxiang ;
Wang, Zhiwei ;
Che, Mingxin ;
Chiao, Paul J. ;
Abbruzzese, James L. ;
Sarkar, Fazlul H. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (04) :906-917
[10]   A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6 [J].
Baughn, Linda B. ;
Di Liberto, Maurizio ;
Wu, Kaida ;
Toogood, Peter L. ;
Louie, Tracey ;
Gottschalk, Rachel ;
Niesvizky, Ruben ;
Cho, Hearn ;
Ely, Scott ;
Moore, Malcolm A. S. ;
Chen-Kiang, Selina .
CANCER RESEARCH, 2006, 66 (15) :7661-7667